The contemporary landscape of psychiatric research and psychopharmacology is experiencing a fundamental renaissance, driven by the exploration of classical psychedelics for treatment-resistant psychological conditions. Across international jurisdictions spanning the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland, clinical investigators and neuroscientists are intensely evaluating the therapeutic utility […]